Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial von Tameris, Michele D, Dr, Hatherill, Mark, FCP, Landry, Bernard S, MPH, Scriba, Thomas J, PhD, Snowden, Margaret Ann, MPH, Lockhart, Stephen, DM, Shea, Jacqueline E, PhD, McClain, J Bruce, MD, Hussey, Gregory D, Prof, Hanekom, Willem A, Prof, Mahomed, Hassan, MMed, McShane, Helen, Prof

Volltext

Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study von Andrews, Jason R, Dr, Nemes, Elisa, PhD, Tameris, Michele, MBChB, Landry, Bernard S, MPH, Mahomed, Hassan, PhD, McClain, J Bruce, MD, Fletcher, Helen A, PhD, Hanekom, Willem A, PhD, Wood, Robin, Prof, McShane, Helen, Prof, Scriba, Thomas J, PhD, Hatherill, Mark, Prof

Volltext

The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial von Geldenhuys, Hennie, Mearns, Helen, Miles, David J.C, Tameris, Michele, Hokey, David, Shi, Zhongkai, Bennett, Sean, Andersen, Peter, Kromann, Ingrid, Hoff, Søren T, Hanekom, Willem A, Mahomed, Hassan, Hatherill, Mark, Scriba, Thomas J, van Rooyen, Michele, Bruce McClain, J, Ryall, Robert, de Bruyn, Guy

Volltext

The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4+ and CD8+ T Cells in Adults von ABEL, Brian, TAMERIS, Michele, HAWKRIDGE, Anthony, VELDSMAN, Ashley, HATHERILL, Mark, SCHIRRU, Giulia, PAU, Maria Grazia, HENDRIKS, Jenny, WEVERLING, Gerrit Jan, GOUDSMIT, Jaap, SIZEMORE, Donata, BRUCE MCCLAIN, J, MANSOOR, Nazma, GOETZ, Margaret, GEARHART, Jacqueline, MAHOMED, Hassan, HUSSEY, Gregory D, SADOFF, Jerald C, HANEKOM, Willem A, GELDERBLOEM, Sebastian, HUGHES, Jane, ABRAHAMS, Deborah, MAKHETHE, Lebohang, ERASMUS, Mzwandile, DE KOCK, Marwou, VAN DER MERWE, Linda

Volltext

Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials von Norrby, Maria, Vesikari, Timo, Lindqvist, Lars, Maeurer, Markus, Ahmed, Raija, Mahdavifar, Shahnaz, Bennett, Sean, McClain, J. Bruce, Shepherd, Barbara M, Li, Daner, Hokey, David A, Kromann, Ingrid, Hoff, Søren T, Andersen, Peter, de Visser, Adriëtte W, Joosten, Simone A, Ottenhoff, Tom H.M, Andersson, Jan, Brighenti, Susanna

Volltext

Cytomegalovirus infection is a risk factor for tuberculosis disease in infants von Müller, Julius, Tanner, Rachel, Matsumiya, Magali, Snowden, Margaret A, Landry, Bernard, Satti, Iman, Harris, Stephanie A, O'Shea, Matthew K, Stockdale, Lisa, Marsay, Leanne, Chomka, Agnieszka, Harrington-Kandt, Rachel, Thomas, Zita-Rose Manjaly, Naranbhai, Vivek, Stylianou, Elena, Mbandi, Stanley Kimbung, Hatherill, Mark, Hussey, Gregory, Mahomed, Hassan, Tameris, Michele, McClain, J Bruce, Evans, Thomas G, Hanekom, Willem A, Scriba, Thomas J, McShane, Helen, Fletcher, Helen A

Volltext

Rabies virus neutralizing activity, pharmacokinetics, and safety of the monoclonal antibody mixture SYN023 in combination with rabies vaccination: Results of a phase 2, randomized,... von McClain, J. Bruce, Chuang, Ariel, Reid, Caroline, Moore, Susan M., Tsao, Eric

Volltext

T-cell activation is an immune correlate of risk in BCG vaccinated infants von Fletcher, Helen A., Snowden, Margaret A., Landry, Bernard, Rida, Wasima, Satti, Iman, Harris, Stephanie A., Matsumiya, Magali, Tanner, Rachel, O’Shea, Matthew K., Dheenadhayalan, Veerabadran, Bogardus, Leah, Stockdale, Lisa, Marsay, Leanne, Chomka, Agnieszka, Harrington-Kandt, Rachel, Manjaly-Thomas, Zita-Rose, Naranbhai, Vivek, Stylianou, Elena, Darboe, Fatoumatta, Penn-Nicholson, Adam, Nemes, Elisa, Hatherill, Mark, Hussey, Gregory, Mahomed, Hassan, Tameris, Michele, McClain, J Bruce, Evans, Thomas G., Hanekom, Willem A., Scriba, Thomas J., McShane, Helen

Volltext

A phase 2b, Randomized, double blinded comparison of the safety and efficacy of the monoclonal antibody mixture SYN023 and human rabies immune globulin in patients exposed to rabie... von Quiambao, Beatriz P., Payumo, Ronald Allan, Roa, Camilo, Borja-Tabora, Charissa Fay, Emmeline Montellano, May, Reyes, Mari Rose De Los, Zoleta-De Jesus, Loreta, Capeding, Maria Rosario, Solimen, Domingo P., Barez, Marie Yvette, Reid, Caroline, Chuang, Ariel, Tsao, Eric, McClain, J. Bruce

Volltext

A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity von Hoft, Daniel F, Blazevic, Azra, Stanley, Jaime, Landry, Bernard, Sizemore, Donata, Kpamegan, Eloi, Gearhart, Jacqueline, Scott, Alison, Kik, Sandra, Pau, Maria G, Goudsmit, Jaap, McClain, J. Bruce, Sadoff, Jerald

Volltext

Safety, Pharmacokinetics, and Neutralizing Activity of SYN023, a Mixture of Two Novel Antirabies Monoclonal Antibodies Intended for Use in Postrabies Exposure Prophylaxis von McClain, J. Bruce, Chuang, Ariel, Moore, Susan M., Tsao, Eric

Volltext

The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3) von Churchyard, Gavin John, Snowden, Margaret Ann, Hokey, David, Dheenadhayalan, Veerabadran, McClain, J Bruce, Douoguih, Macaya, Pau, Maria Grazia, Sadoff, Jerry, Landry, Bernard

Volltext

Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial von van Zyl-Smit, Richard N, Esmail, Aliasgar, Bateman, Mary E, Dawson, Rodney, Goldin, Jonathan, van Rikxoort, Eva, Douoguih, Macaya, Pau, Maria Grazia, Sadoff, Jerald C, McClain, J Bruce, Snowden, Margaret Ann, Benko, Jacqueline, Hokey, David A, Rutkowski, Kathryn Tucker, Graves, Andrew, Shepherd, Barbara, Ishmukhamedov, Sadritdin, Kagina, Benjamin M N, Abel, Brian, Hanekom, Willem A, Scriba, Thomas J, Bateman, Eric D

Volltext

The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4+ T cell counts >350 cells/mm3 von Churchyard, Gavin John, Snowden, Margaret Ann, Hokey, David, Dheenadhayalan, Veerabadran, McClain, J. Bruce, Douoguih, Macaya, Pau, Maria Grazia, Sadoff, Jerry, Landry, Bernard

Volltext

Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON® -TB Gold (+) Kenyan adults without evide... von Walsh, Douglas S, Owira, Victorine, Polhemus, Mark, Otieno, Lucas, Andagalu, Ben, Ogutu, Bernhards, Waitumbi, John, Hawkridge, Anthony, Shepherd, Barbara, Pau, Maria Grazia, Sadoff, Jerald, Douoguih, Macaya, McClain, J. Bruce

Volltext

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG von Tameris, Michele, McShane, Helen, McClain, J. Bruce, Landry, Bernard, Lockhart, Stephen, Luabeya, Angelique K.K, Geldenhuys, Hennie, Shea, Jacqui, Hussey, Gregory, van der Merwe, Linda, de Kock, Marwou, Scriba, Thomas, Walker, Robert, Hanekom, Willem, Hatherill, Mark, Mahomed, Hassan

Volltext

Correction: Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants von Fletcher, Helen A., Snowden, Margaret A., Landry, Bernard, Rida, Wasima, Satti, Iman, Harris, Stephanie A., Matsumiya, Magali, Tanner, Rachel, O’Shea, Matthew K., Dheenadhayalan, Veerabadran, Bogardus, Leah, Stockdale, Lisa, Marsay, Leanne, Chomka, Agnieszka, Harrington-Kandt, Rachel, Manjaly-Thomas, Zita-Rose, Naranbhai, Vivek, Stylianou, Elena, Darboe, Fatoumatta, Penn-Nicholson, Adam, Nemes, Elisa, Hatherill, Mark, Hussey, Gregory, Mahomed, Hassan, Tameris, Michele, McClain, J. Bruce, Evans, Thomas G., Hanekom, Willem A., Scriba, Thomas J., McShane, Helen

Volltext

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants von Fletcher, Helen A, Snowden, Margaret A, Landry, Bernard, Rida, Wasima, Satti, Iman, Harris, Stephanie A, Matsumiya, Magali, Tanner, Rachel, O'Shea, Matthew K, Dheenadhayalan, Veerabadran, Bogardus, Leah, Stockdale, Lisa, Marsay, Leanne, Chomka, Agnieszka, Harrington-Kandt, Rachel, Manjaly-Thomas, Zita-Rose, Naranbhai, Vivek, Stylianou, Elena, Darboe, Fatoumatta, Penn-Nicholson, Adam, Nemes, Elisa, Hatherill, Mark, Hussey, Gregory, Mahomed, Hassan, Tameris, Michele, McClain, J Bruce, Evans, Thomas G, Hanekom, Willem A, Scriba, Thomas J, McShane, Helen

Volltext

Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial von Ndiaye, Birahim Pierre, MD, Thienemann, Friedrich, MD, Ota, Martin, FWACP, Landry, Bernard S, MPH, Camara, Makhtar, PhD, Dièye, Siry, MD, Dieye, Tandakha Ndiaye, PhD, Esmail, Hanif, MRCP, Goliath, Rene, BSc, Huygen, Kris, PhD, January, Vanessa, Ndiaye, Ibrahima, MD, Oni, Tolu, MD, Raine, Michael, BSc, Romano, Marta, PhD, Satti, Iman, PhD, Sutton, Sharon, BS, Thiam, Aminata, MD, Wilkinson, Katalin A, PhD, Mboup, Souleymane, Prof, Wilkinson, Robert J, Prof, McShane, Helen, Prof

Volltext

An outbreak of spotted fever rickettsiosis in U.S. Army troops deployed to Botswana von Smoak, B L, McClain, J B, Brundage, J F, Broadhurst, L, Kelly, D J, Dasch, G A, Miller, R N

Volltext